Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either gram negative or gram positive bacteria

BackgroundIn the ICU, bacteremia is a life-threatening infection whose prognosis is highly dependent on early recognition and treatment with appropriate antibiotics. Procalcitonin levels have been shown to distinguish between bacteremia and noninfectious inflammatory states accurately and quickly in critically ill patients. However, we still do not know to what extent the magnitude of PCT elevation at the onset of bacteremia varies according to the Gram stain result.MethodsReview of the medical records of every patient treated between May, 2004 and December, 2006 who had bacteremia caused by either Gram positive (GP) or Gram negative (GN) bacteria, and whose PCT dosage at the onset of infection was available.Results97 episodes of either GN bacteremia (n = 52) or GP bacteremia (n = 45) were included. Procalcitonin levels were found to be markedly higher in patients with GN bacteremia than in those with GP bacteremia, whereas the SOFA score value in the two groups was similar. Moreover, in the study population, a high PCT value was found to be independently associated with GN bacteremia. A PCT level of 16.0 ng/mL yielded an 83.0% positive predictive value and a 74.0% negative predictive value for GN-related bacteremia in the study cohort (AUROCC = 0.79; 95% CI, 0.71–0.88).ConclusionIn a critically ill patient with clinical sepsis, GN bacteremia could be associated with higher PCT values than those found in GP bacteremia, regardless of the severity of the disease.

[1]  H. Schächinger,et al.  Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit , 2000, Critical care medicine.

[2]  R. Wenzel,et al.  Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  K. Chapin,et al.  Effects of Rapid Detection of Bloodstream Infections on Length of Hospitalization and Hospital Charges , 2003, Journal of Clinical Microbiology.

[4]  M. Meisner,et al.  Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS , 1999, Critical care.

[5]  M. Christ-Crain,et al.  Procalcitonin in bacterial infections--hype, hope, more or less? , 2005, Swiss medical weekly.

[6]  J. Timsit,et al.  Excess risk of death from intensive care unit-acquired nosocomial bloodstream infections: a reappraisal. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  D. Pittet,et al.  Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. , 1994, JAMA.

[8]  L. Hansson,et al.  Procalcitonin and C-Reactive Protein Levels in Community-Acquired Pneumonia: Correlation with Etiology and Prognosis , 2000, Infection.

[9]  J. Pugin,et al.  Contribution of Toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria. , 2007, Blood.

[10]  J. Vincent,et al.  Procalcitonin used as a marker of infection in the intensive care unit. , 1999, Critical care medicine.

[11]  K. Chapin,et al.  Detection and Treatment of Bloodstream Infection: Laboratory Reporting and Antimicrobial Management , 2003, Journal of Clinical Microbiology.

[12]  S. Opal,et al.  Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis? , 1999, Critical care medicine.

[13]  M. Higgins,et al.  The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. , 1999, American journal of respiratory and critical care medicine.

[14]  B. A. Forbes,et al.  Time to Blood Culture Positivity as a Predictor of Clinical Outcome of Staphylococcus aureus Bloodstream Infection , 2006, Journal of Clinical Microbiology.

[15]  E. Polati,et al.  Comparison of procalcitonin and C-reactive protein as markers of sepsis. , 2003, Critical care medicine.

[16]  G Sherman,et al.  The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. , 2000, Chest.

[17]  A. Rudin,et al.  Pattern of Cytokine Responses to Gram‐Positive and Gram‐Negative Commensal Bacteria is Profoundly Changed when Monocytes Differentiate into Dendritic Cells , 2004, Infection and Immunity.

[18]  B. Hoen,et al.  Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  Á. Pallares,et al.  Procalcitonin and neopterin correlation with aetiology and severity of pneumonia. , 2006, The Journal of infection.

[20]  C. Clec’h,et al.  Diagnostic and prognostic value of procalcitonin in patients with septic shock , 2004, Critical care medicine.

[21]  S. Opal,et al.  The duration of hypotension before the initiation of antibiotic treatment is a critical determinant of survival in a murine model of Escherichia coli septic shock: association with serum lactate and inflammatory cytokine levels. , 2006, The Journal of infectious diseases.

[22]  P. Devos,et al.  Diagnostic and Prognostic Values of Admission Procalcitonin Levels in Community–Acquired Pneumonia in an Intensive Care Unit , 2005, Infection.

[23]  D. Pittet,et al.  Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. , 2001, American journal of respiratory and critical care medicine.

[24]  E. Tavares,et al.  Circulating Inflammatory Mediators during Start of Fever in Differential Diagnosis of Gram-Negative and Gram-Positive Infections in Leukopenic Rats , 2005, Clinical Diagnostic Laboratory Immunology.

[25]  H. D. Liggitt,et al.  Cutting Edge: Myeloid Differentiation Factor 88 Is Essential for Pulmonary Host Defense against Pseudomonas aeruginosa but Not Staphylococcus aureus1 , 2004, The Journal of Immunology.

[26]  Patrick Nicolas,et al.  Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: A systematic review and meta-analysis , 2006, Critical care medicine.

[27]  J. Quenot,et al.  Serum procalcitonin measurement contribution to the early diagnosis of candidemia in critically ill patients , 2006, Intensive Care Medicine.

[28]  Á. Soriano,et al.  Relationship of Phylogenetic Background, Biofilm Production, and Time to Detection of Growth in Blood Culture Vials with Clinical Variables and Prognosis Associated with Escherichia coli Bacteremia , 2006, Journal of Clinical Microbiology.

[29]  B. Kocazeybek,et al.  Procalcitonin and C-Reactive Protein in Infective Endocarditis: Correlation with Etiology and Prognosis , 2003, Chemotherapy.